Time to end secret data laboratories—starting with the CDC
The American people are waking up to the fact that too many public health leaders have not always been straight with them. Despite housing treasure…
Thought Leader: Marty Makary
Dr. Scott Gottlieb on the impact of Pres. Trump’s policies on Big Pharma and R&D
Former FDA Commissioner Dr. Scott Gottlieb joins ‘Squawk Box’ to discuss the impact of President Trump’s tariff policy and executive order on the pharmaceutical industry, impact on R&D and new drug development, and more.
Dr. Scott Gottlieb, former FDA Commissioner, brings deep insight into the intersection of healthcare policy and pharmaceutical innovation. With extensive experience in public health leadership, he provides expert analysis on the impacts of regulation, tariffs, and industry trends. For speaking inquiries, contact WWSG.
Relevant posts
Newt Gingrich | Election 2024 – State of the Race
Newt Gingrich discusses the upcoming election with two experienced pollsters, John McLaughlin and Doug Sosnik. They discuss key issues voters are considering, the six or…
Jay Clayton on taxing unrealized gains, price gouging ban proposals
Former SEC Chair Jay Clayton joins ‘Squawk Box’ to discuss the Trump vs. Harris economic agendas, taxing unrealized capital gains, federal price gouging ban, and…
More with this speaker
Scott Gottlieb on Ebola Outbreak
Thought Leader: Scott Gottlieb
Scott Gottlieb Joins Face the Nation
Thought Leader: Scott Gottlieb
